Full name
ORAWSKA INSIEME SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
73.12.D - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,3 | -0,2 | 31,4 |
EBITDA | 0 | -0,2 | -0,1 | 72,8 |
Short time liabilities | 1,3 | 1,8 | 2,8 | 51,9 |
Equity capital | -0,4 | -0,6 | -0,9 | -40,1 |
Operating profit (EBIT) | 0 | -0,2 | -0,1 | 61 |
Assets | 1 | 1,2 | 1,9 | 57,4 |
Net profit (loss) | 0 | -0,2 | -0,3 | -12,5 |
Cash | 0 | 0,1 | 0,3 | 394,7 |
Liabilities and provisions for liabilities | 1,4 | 1,8 | 2,8 | 51,4 |
Net income from sale | 4,4 | 4,9 | 5,5 | 12,4 |
Working assets | 0,7 | 1 | 1,7 | 79,1 |
Depreciation | 0 | 0 | 0 | 14,8 |
% | % | % | p.p. | |
Profitability of capital | -1,3 | 35,7 | 28,6 | -7,1 |
Equity capital to total assets | -43,5 | -54 | -48 | 6 |
Gross profit margin | -0,1 | -5,7 | -3,5 | 2,2 |
EBITDA Margin | 0,5 | -4,2 | -1 | 3,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 112 | 136 | 183 | 47 |
Current financial liquidity indicator | 0.5567500591278076 | 0.5355291366577148 | 0.6311520338058472 | 0,1 |
Net dept to EBITDA | 14.245975494384766 | -2.7263588905334473 | -16.028797149658203 | -13,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane